Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT1A weak partial agonistic activity showing the antidepressant-like effect
作者:Hidefumi Yoshinaga、Shuji Masumoto、Koji Koyama、Naoya Kinomura、Yuji Matsumoto、Taro Kato、Satoko Baba、Kenji Matsumoto、Tomoko Horisawa、Hitomi Oki、Kazuki Yabuuchi、Toru Kodo
DOI:10.1016/j.bmc.2016.10.034
日期:2017.1
We report the discovery of a novel benzylpiperidine derivative with serotonin transporter (SERT) inhibitory activity and 5-HT1A receptor weak partial agonistic activity showing the antidepressant-like effect. The 3-methoxyphenyl group and the phenethyl group of compound 1, which has weak SERT binding activity, but potent 5-HT1A binding activity, were optimized, leading to compound 35 with potent and
我们报告发现具有5-羟色胺转运蛋白(SERT)抑制活性和5-HT1A受体弱部分激动活性的新型苄基哌啶衍生物,显示出抗抑郁样作用。优化了化合物1的3-甲氧基苯基和苯乙基,它们具有弱的SERT结合活性,但具有有效的5-HT1A结合活性,从而导致化合物35具有有效且平衡的双重SERT和5-HT1A结合活性,而且有效的CYP2D6抑制活性。用较大的烷氧基(例如乙氧基,异丙氧基或甲氧基-乙氧基)代替化合物35左侧部分中的甲氧基可改善CYP2D6的抑制作用,从而使SMP-304成为候选化合物。具有5-羟色胺摄取抑制活性和5-HT1A弱局部激动活性的SMP-304,可作为5-HT1A拮抗剂起作用,